{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=59", "query": { "intervention": "Control Study Product", "page": 59 }, "page_size": 10 }, "pagination": { "page": 59, "page_size": 10, "total_count": 4239, "total_pages": 424, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=60&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=58&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T05:50:56.456Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03277573", "title": "Salsalate in Patients Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "Salsalate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Adam Boxer", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 40, "start_date": "2017-07-21", "completion_date": "2023-04-10", "has_results": false, "last_update_posted_date": "2025-04-16", "last_synced_at": "2026-10-31T05:50:56.456Z", "location_count": 2, "location_summary": "San Diego, California • San Francisco, California", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03277573" }, { "nct_id": "NCT00964561", "title": "Ph1 Study of Valortim and Ciprofloxacin in Humans", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Anthrax" ], "interventions": [ { "name": "Ciprofloxacin and Valortim", "type": "DRUG" }, { "name": "Placebo Antibiotic and Valortim", "type": "DRUG" }, { "name": "Placebo Antibiotic and Placebo Valortim", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "PharmAthene, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "18 Years to 59 Years" }, "enrollment_count": 26, "start_date": "2009-08", "completion_date": "2010-07", "has_results": false, "last_update_posted_date": "2010-08-10", "last_synced_at": "2026-10-31T05:50:56.456Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00964561" }, { "nct_id": "NCT07103083", "title": "Postprandial Response to Fruit Juice", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Blood Glucose", "Blood Insulin" ], "interventions": [ { "name": "Beverage 1", "type": "DIETARY_SUPPLEMENT" }, { "name": "Beverage 2", "type": "DIETARY_SUPPLEMENT" }, { "name": "Beverage 3", "type": "DIETARY_SUPPLEMENT" }, { "name": "Beverage 4", "type": "DIETARY_SUPPLEMENT" }, { "name": "Beverage 5", "type": "DIETARY_SUPPLEMENT" }, { "name": "Beverage 6", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Ocean Spray Cranberries, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 18, "start_date": "2025-07-21", "completion_date": "2025-10-29", "has_results": false, "last_update_posted_date": "2025-08-05", "last_synced_at": "2026-10-31T05:50:56.456Z", "location_count": 1, "location_summary": "Addison, Illinois", "locations": [ { "city": "Addison", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07103083" }, { "nct_id": "NCT00920959", "title": "Advair Pediatric Once-Daily", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FP 100mcg", "type": "DRUG" }, { "name": "FSC 100/50mcg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 908, "start_date": "2001-11", "completion_date": "2004-01", "has_results": false, "last_update_posted_date": "2016-09-15", "last_synced_at": "2026-10-31T05:50:56.456Z", "location_count": 141, "location_summary": "Ozark, Alabama • Tucson, Arizona • Little Rock, Arkansas + 118 more", "locations": [ { "city": "Ozark", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00920959" }, { "nct_id": "NCT03938246", "title": "Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)" ], "interventions": [ { "name": "TVB-2640 25 mg (US)", "type": "DRUG" }, { "name": "TVB-2640 50 mg (US)", "type": "DRUG" }, { "name": "Placebo (US)", "type": "DRUG" }, { "name": "TVB-2640 50 mg (China)", "type": "DRUG" }, { "name": "Placebo (China)", "type": "DRUG" }, { "name": "TVB-2640 75 mg (US)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sagimet Biosciences Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 142, "start_date": "2019-03-22", "completion_date": "2021-10-02", "has_results": true, "last_update_posted_date": "2024-12-19", "last_synced_at": "2026-10-31T05:50:56.456Z", "location_count": 12, "location_summary": "Chula Vista, California • Montclair, California • Sacramento, California + 9 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Montclair", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03938246" }, { "nct_id": "NCT06436183", "title": "A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis", "Atopic", "Dermatitis", "Dermatologic Disease", "Eczema", "Eczema Atopic Dermatitis", "Eczema, Atopic" ], "interventions": [ { "name": "Camoteskimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Apollo Therapeutics Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 62, "start_date": "2024-05-01", "completion_date": "2025-08-12", "has_results": false, "last_update_posted_date": "2025-09-18", "last_synced_at": "2026-10-31T05:50:56.456Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Encinitas, California • Fountain Valley, California + 23 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06436183" }, { "nct_id": "NCT06142383", "title": "A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "XXB750 Low dose", "type": "BIOLOGICAL" }, { "name": "XXB750 Medium Dose", "type": "BIOLOGICAL" }, { "name": "XXB750 High Dose", "type": "BIOLOGICAL" }, { "name": "Sacubitril/valsartan", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 136, "start_date": "2023-12-12", "completion_date": "2024-11-01", "has_results": true, "last_update_posted_date": "2026-01-27", "last_synced_at": "2026-10-31T05:50:56.456Z", "location_count": 14, "location_summary": "Dothan, Alabama • Huntsville, Alabama • Inverness, Florida + 11 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Inverness", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Wellington", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06142383" }, { "nct_id": "NCT00835861", "title": "Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non Insulin Dependent Diabetes", "Pregnancy" ], "interventions": [ { "name": "Metformin", "type": "DRUG" }, { "name": "Insulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 31, "start_date": "2008-08", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2017-04-25", "last_synced_at": "2026-10-31T05:50:56.456Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00835861" }, { "nct_id": "NCT02395042", "title": "A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cystitis, Interstitial", "Ulcer" ], "interventions": [ { "name": "LiRIS®", "type": "DRUG" }, { "name": "LiRIS Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 59, "start_date": "2015-04-15", "completion_date": "2017-11-20", "has_results": true, "last_update_posted_date": "2018-10-05", "last_synced_at": "2026-10-31T05:50:56.456Z", "location_count": 17, "location_summary": "Murrieta, California • Vacaville, California • Farmington, Connecticut + 14 more", "locations": [ { "city": "Murrieta", "state": "California" }, { "city": "Vacaville", "state": "California" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Alpharetta", "state": "Georgia" }, { "city": "Annapolis", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02395042" }, { "nct_id": "NCT04812262", "title": "A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Overweight and Obesity", "Type2 Diabetes", "NAFLD" ], "interventions": [ { "name": "DD01", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neuraly, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 255, "start_date": "2021-02-24", "completion_date": "2023-02-14", "has_results": false, "last_update_posted_date": "2024-04-29", "last_synced_at": "2026-10-31T05:50:56.456Z", "location_count": 3, "location_summary": "Chula Vista, California • Fort Myers, Florida • Orlando, Florida", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04812262" } ] }